A comparative analysis of fetal mirror-image dextrocardia in China pre- and post-COVID-19 lockdown lifting Authors: Wenjiao Xu, Yajuan Wei, Xinru Gao, Xiaoxue Yang, Jianrong Gao, Shanying He, Huanhuan Huo, Min Qiao, Xiaohua Dong, Wei Chen, Enfa Zhao, Baomin Liu Published: 2026 ABSTRACT AbstractObjectiveTo analyze the epidemiological characteristics and incidence of mirror-image dextrocardia in pregnant women and fetuses before and after the lifting of coronavirus disease (COVID-19) control measures in China on December 7, 2022.MethodsWe retrospectively collected data on the number of pregnant women who underwent prenatal ultrasound examinations and incidence of mirror-image dextrocardia in fetuses at three hospitals in Xi'an during three time periods: before the COVID-19 pandemic (January to April 2019), during the COVID-19 control measures (January to April 2022), and after the lifting of COVID-19 restrictions (January to April 2023). We then conducted an online epidemiological survey among pregnant women across China and collected the names of pregnant women with fetal mirror dextrocardia, as well as the following clinical information: age, location (province and city), gestational week at which mirror-image dextrocardia was detected, last menstrual period date, date of first pregnancy diagnosis, obstetric history, conception method, estimated due date, ultrasound diagnosis result, and genetic testing result. COVID-19-related information was also recorded.ResultsBetween January and April 2019 (pre-pandemic), 9,112 pregnant women underwent prenatal ultrasound examinations at 3 hospitals in Xi'an. Between January and April 2022 (COVID-19 control measures period), 11,071 pregnant women underwent prenatal ultrasound examinations, and 1 case of fetus with mirror-image dextrocardia was identified (incidence rate, 0.9/10,000). Between January and April 2023 (after the lifting of COVID-19 restrictions), 11,516 pregnant women underwent prenatal ultrasound examinations, and 21 fetuses with mirror-image dextrocardia were detected, with an alarming incidence rate of 18.2/10,000. After the lifting of COVID-19 restrictions, the incidence of mirror-image dextrocardia in fetuses in Xi'an showed a significant increase (8–20-fold higher) compared to that observed in both the pre-pandemic and strictly controlled pandemic periods. An online investigation showed that 111 cases of fetal mirror-image dextrocardia were detected in 22 other provinces of China after the lifting of COVID-19 restrictions. All pregnant women with fetal mirror-image dextrocardia had a history of SARS-CoV-2 infection after the lifting of COVID-19 restrictions, which coincided with the early stages of embryo development, approximately 4–6 weeks after their last menstrual period.ConclusionsOur data showed that the increase in cases of fetal situs solitus with dextrocardia coincided temporally with the outbreak of COVID-19 in China. This temporal overlap may suggest a potential association between the two events.Keywords: COVID-19, Pandemic, Mirror-image dextrocardia, Incidence rate, Epidemiology Background Coronavirus disease (COVID-19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family of severe acute respiratory syndrome coronaviruses [1]. As of April 30, 2023, more than 765 million confirmed cases of COVID-19 and more than 6.9 million deaths have been reported globally [2]. The pandemic has caused colossal harm to human health and well-being, while also severely impacting the global economy, employment, education, and societal activities. Amidst the continuous evolution and mutations of the novel coronavirus, various novel strains, such as Alpha, Beta, Gamma, and Delta, have emerged, with the latter displaying strong contagiousness, short incubation period, high pathogenicity, and rapid disease progression [3–6]. The Delta strain has gradually become the predominant viral strain in India and worldwide, resulting in the resurgence of cases in multiple countries and regions [7]. Moreover, in 2022, the Omicron variant has quickly spread across China after the government relaxed its control measures [8]. On December 7, 2022, the Chinese government lifted the restrictions on controlling the COVID-19 pandemic, which resulted in an explosive increase in the SARS-CoV-2 infection rate among the Chinese population, as well as in the number of positive nucleic acid test results. The reported SARS-CoV-2 infection rate peaks between December 19 and December 21, 2022 (15.5%). As of February 7, 2023, approximately 82.4% of China’s population have been infected [9]. Thereafter, the incidence of COVID-19 rapidly declined and returned to a state similar to that before the pandemic. The COVID-19 pandemic has raised concerns regarding the potential impact of SARS-CoV-2 infection on maternal and fetal health outcomes. Emerging evidence suggests that the pandemic may have exacerbated existing health disparities and increased the risk of adverse pregnancy outcomes, including congenital anomalies [10]. One such anomaly is mirror-image dextrocardia, a rare condition in which the heart is located on the right side of the chest instead of the left. Previous studies have shown that environmental factors, such as maternal infections, can contribute to the occurrence of congenital anomalies in fetuses [11, 12]. Recent data suggest that the COVID-19 pandemic may be associated with an increased risk of adverse pregnancy outcomes, including preterm birth, fetal distress, and congenital anomalies [13, 14]. However, the relationship between the COVID-19 pandemic and fetal mirror-image dextrocardia remains unknown. In this study, we aimed to analyze the epidemiological characteristics and incidence rate of mirror-image dextrocardia in pregnant women and fetuses before and after the lifting of the COVID-19 control measures in China on December 7, 2022. We retrospectively collected data from three hospitals in Xi'an and conducted an online epidemiological survey among pregnant women across China to investigate the potential relationship between the COVID-19 pandemic and occurrence of mirror-image dextrocardia in fetuses. This research is important to understand the impact of COVID-19 on maternal and fetal health and to inform public health policies related to the management of pandemics during pregnancy. Materials and methods Population and methods The first phase of this retrospective study was conducted at three leading hospitals in Xi'an, Shaanxi Province: Xi'an International Medical Center Hospital, Northwest Women and Children's Hospital, and Xi'an Angel Maternal and Child Health Hospital.The study covered three distinct periods: January—April 2019 (pre—COVID—19 outbreak), January—April 2022 (during the government's strict containment measures when no large—scale outbreaks occurred [Control Period]), and January—April 2023 (after the government relaxed restrictions when large—scale outbreaks occurred [Non—Control Period]).The primary objective was to compare the incidence of fetoscopic mirror—image dextrocardia through data analysis.Participants were pregnant women whose fetal ultrasound examinations in this study were performed by attending physicians or above with formal prenatal screening qualifications. The targeted fetal anatomical scans were conducted during the second trimester. The positions of visceral organs, including the heart, liver, spleen, stomach bubble, as well as the midline structures, were systematically evaluated.Finally, only pregnant women with imaging—confirmed mirror—image dextrocardia were included as the research subjects.This study was approved by the Ethics Committee of Xi'an International Medical Center Hospital. The second phase was a prospective study that utilized a nationwide research cohort to investigate the cardiac characteristics of mirror—image dextrocardia after COVID—19. The online epidemiological survey for this study was conducted from January to April 2023.A nationwide community outbreak of SARS—CoV—2 occurred in December 2022, when nucleic acid testing had been widely adopted as a daily routine screening measure across the country. Accordingly, SARS—CoV—2 infection was confirmed by positive nucleic acid results, and the date of the first positive nucleic acid test was defined as the infection date.Detailed information was collected on pregnant women with confirmed fetal mirror—image dextrocardia in China (including Shaanxi Province). A total of 115 pregnant women were included through the online epidemiological survey, and 4 cases were excluded due to incomplete questionnaire data (missing last menstrual date and SARS—CoV—2 infection data). Ultimately, this study analyzed 111 cases of mirror—image dextrocardia. Variables and data collection We employed traditional epidemiological methods to investigate pregnant women who underwent routine prenatal ultrasound examinations at three hospitals in Xi'an. For pregnant women with fetal mirror—image dextrocardia during prenatal ultrasound screening between January and April 2023, we gathered the following detailed information through an online QR code questionnaire: province/city of residence, gestational week when fetal mirror—image dextrocardia was first detected, date of last menstrual period, date of first discovery of pregnancy, obstetric history, mode of conception, expected delivery date, medication history, history of exposure to radioactive materials, and family history of genetic diseases. For the epidemiological investigation of the pandemic, we aimed to determine the time of SARS-CoV-2 infection, nucleic acid test results, the presence or absence of fever, the maximum temperature, the duration of fever, coughing, sputum production, sore throat, diarrhea, loss of taste, drowsiness, body aches, and other symptoms.To conduct this investigation, we used an online epidemiological survey questionnaire that required participants to provide their real names and contact information, which would not be publicly disclosed. This safeguarded personal privacy while helping us collect accurate information. This study adopted voluntary participation and online completion as methods, and measures were taken to ensure the reliability of online survey data. When enrolling patients, we required them to provide ultrasound examination reports from at least two independent hospitals to cross—verify the diagnosis of "mirror—image dextrocardia". We rigorously reviewed the internal consistency of key dates (last menstrual period date, SARS-CoV-2 infection date, and ultrasound diagnosis date) in all cases. Statistical analysis We established a database based on individual summary data from the questionnaire. Data were analyzed using the SPSS software (IBM SPSS 26.0, SPSS Inc.). Data comparison between groups was conducted using the chi—square (χ2) test, with P < 0.05 indicating statistical significance. The mean, range, percentage, and dispersion coefficients were employed for descriptive analyses of the data. Results Incidence rate of fetal mirror—image dextrocardia in three time periods From January to April 2019, prior to the COVID—19 pandemic, three hospitals in Xi'an, Shaanxi Province, recorded a total of 9,112 pregnant women who underwent prenatal ultrasound examinations. Similarly, during the same period in 2022, when the pandemic was under control, these hospitals documented 11,071 pregnant women undergoing prenatal ultrasound examinations (Table 1). We observed no statistically significant difference in the incidence rates of fetal mirror—image dextrocardia between the two time periods (Fig. 1).However, during the uncontrolled period from January to April 2023, we found a significant increase in the incidence rate of fetal mirror—image dextrocardia (18.2/10000), which was markedly higher than that in the periods prior to the COVID—19 pandemic and during the pandemic control (all P < 0.001). Table 1Incidence of fetal mirror-image dextrocardia prior to the COVID-19 pandemic and during controlled and uncontrolled periods in three hospitalsTime periodsNumber of pregnant women with fetal mirror-image dextrocardiaNumber of pregnant women without fetal mirror-image dextrocardiaNumber of pregnant womenIncidence rateJanuary to April 20192911091122.2/10000January to April 2022111,07011,0710.9/10000January to April 20232111,49511,51618.2/10000 Incidence of fetal mirror-image dextrocardia prior to the COVID-19 pandemic and during controlled and uncontrolled periods in three hospitals Incidence rate of fetal mirror-image dextrocardia prior to the COVID-19 pandemic and during the controlled and uncontrolled periods Relationship between the last menstrual period and the time of SARS-CoV-2 infection Through the investigation of 111 pregnant women with fetal mirror-image dextrocardia, all of whom were infected with SARS-CoV-2, we found that 11 patients had their last menstrual period before November 2022. Ninety-eight (88.2%) cases had their last menstrual period between November 1 and November 20, 2022, and only 2 cases had their last menstrual period after November 21, 2022.The time at which these pregnant women were infected with SARS-CoV-2 was mostly around mid—December 2022, and 106 pregnant women were infected (95.5%). Among pregnant women infected with SARS-CoV-2, 95 (85.6%) had a gestational age of 4–6 weeks (Table 2).Therefore, the most significant feature of these pregnant women was their infection with SARS-CoV-2 4–6 weeks after conception. After SARS-CoV-2 infection, 85.6% of the pregnant women’s gestational ages were concentrated in 4–6 weeks after conception (Fig. 2).Part of the data included in this study has been previously published as a Letter in Archives of Gynecology and Obstetrics, focusing on the association between the last menstrual period and SARS—CoV—2 infection timing among the study cohort. Table 2Dates of the last menstrual period and SARS-CoV-2 infection and the gestational age at the time of SARS-CoV-2 infection in pregnant women with fetal mirror-image dextrocardiaDateNumberPercentageThe date of last menstrual period Before November 1, 2022119.90% November 1, 2022-November 10, 20224944.10% November 11, 2022-November 20, 20224944.10% November 21, 2022-November 31, 202221.90%The date of SARS-CoV-2 infection Before November 1, 202243.60% November 1, 2022-November 10, 20221513.50% November 11, 2022-November 20, 20226154.90% November 21, 2022-November 31, 20223027.10% January 1, 2023-January 31, 202310.90%Gestational age at that time of SARS-CoV-2 infection 2–4 weeks43.60% 4–6 weeks9585.60% 6–24 weeks1210.80% Dates of the last menstrual period and SARS-CoV-2 infection and the gestational age at the time of SARS-CoV-2 infection in pregnant women with fetal mirror-image dextrocardia Curve depicting the date of the last menstrual period and time of SARS-CoV-2 infection in 111 pregnant women with fetal mirror-image dextrocardia. The green curve represents the number of daily pregnant women based on their last menstrual period, whereas the red curve represents the number of pregnant women infected with SARS-CoV-2 per day. The yellow curve is obtained by shifting the red curve forward by 5 weeks, indicating that the date of SARS-CoV-2 infection in pregnant women differs from their last menstrual period by approximately 5 weeks Distribution characteristics and congenital heart defects of pregnant women with fetal mirror—image dextrocardia Between January and April 2023, 111 pregnant women with mirror—image dextrocardia, all of whom had singleton pregnancies, in Shaanxi Province and 21 other provinces in China were investigated. Among them, 29 (26%) women were detected in Shaanxi Province, 18 (16%) in Guangdong Province, 9 (8%) in Henan Province, and 8 (7%) in Shandong Province; the detection rates were relatively low in other provinces (Fig. 3).A total of 46 (41.44%) women were 20–30 years old, and 65 (58.56%) were 30–40 years old. Fifty—four expecting mothers were experiencing pregnancy for the first time, accounting for 48.6% of the total participants.Among the 111 pregnant women, 107 (96.4%) conceived naturally, and only 3.6% conceived by assisted reproduction (Table 3). All pregnant women were vaccinated with more than two doses of the inactivated COVID—19 vaccine before pregnancy, with the last dose administered no less than 6 months prior to conception. Distribution of 111 pregnant women with fetal mirror-image dextrocardia in different provinces Table 3Population distribution characteristics of the 111 pregnant women with fetal mirror-image dextrocardiVariablesNumberPercentageAge (years) 18–304641.44% 30–406558.56%Number of pregnancies 15448.60% 22825.20% 32018.20% 476.30% 521.70%Maternal parity 07365.80% 12926.10% 287.20% 310.90%Mode of conception Natural conception10796.40% Assisted reproductive technology43.60% Population distribution characteristics of the 111 pregnant women with fetal mirror-image dextrocardi Among 111 pregnant women with fetal mirror—image dextrocardia, 95 (85.6%) had isolated mirror—image dextrocardia. Congenital heart defects found in conjunction with the fetal mirror—image dextrocardia included interrupted inferior vena cava (6.3%), ventricular septal defect (3.6%), atrial septal defect (1.8%), left atrial isomerism, right aortic arch, aberrant left subclavian artery, single ventricle, and persistent truncus arteriosus (Fig. 4). Pie chart of isolated mirror-image dextrocardia and mirror-image dextrocardia complicated with other cardiac malformations Among the 111 pregnant women, all experienced coughing and phlegm. Moreover, 105 (94.6%) had a fever (the lowest body temperature being 37.3℃ and the highest being 39.9℃), with an average temperature of 38.7℃. The fever duration ranged from 12 h to 5 days. Additionally, we noted five cases (4.5%) of diarrhea. The primary clinical manifestations of COVID—19 in pregnant women are shown in Fig. 5. Clinical manifestations of pregnant women with fetal mirror-image dextrocardia who tested positive for COVID-19 Genetic testing results in pregnant women with fetal mirror—image dextrocardia Prenatal genetic testing typically comprises non—invasive DNA testing, amniocentesis, and whole—exome sequencing. Among the 36 pregnant women who underwent non—invasive DNA testing, all the results indicated a low risk of triploid abnormalities. Of the 42 pregnant women who had amniocentesis, one tested positive for the CFAP53 gene, which is associated with visceral heterotaxy—6 (OMIM: 614,779), a rare autosomal recessive genetic disorder.Among the 21 pregnant women who underwent whole—exome gene testing, the results were abnormal in two cases. One woman was found to be related to the DNAH5 gene, which is associated with primary ciliary dyskinesia type 3, with or without situs inversus (OMIM: 608,644), a rare genetic disorder characterized by impaired function of the motile cilia. Another woman was detected to have the DNAH11 gene, which is associated with primary ciliary dyskinesia type 7, with or without situs inversus (CILD7; OMIM: 611,884). Follow—up outcomes All 111 pregnant women diagnosed with COVID—19 and carrying a fetus with situs inversus with dextrocardia were enrolled in a structured follow—up program. The follow—up protocol included regular obstetric monitoring, detailed prenatal counseling, and postnatal pediatric cardiology assessment for live births. Postnatal evaluation for infants involved transthoracic echocardiography performed at birth, 6 months, and 2 years of age to assess cardiac structure and function, with a particular focus on the closure status of the foramen ovale. Of the initial cohort of 111 women, 6 (5.4%) were lost to follow—up. Among the remaining 105 participants, 16 (15.2%) opted for pregnancy termination. Reasons for Pregnancy Termination: The primary reasons for termination were: i)diagnosis of concomitant major fetal cardiac structural abnormalities (including single ventricle, persistent truncus arteriosus, and atrioventricular septal defect); diagnosis of concomitant major fetal cardiac structural abnormalities (including single ventricle, persistent truncus arteriosus, and atrioventricular septal defect); ii)detection of pathogenic genetic microarray anomalies; and. detection of pathogenic genetic microarray anomalies; and. iii)maternal anxiety regarding the unknown long—term effects of COVID—19 on fetal development. maternal anxiety regarding the unknown long—term effects of COVID—19 on fetal development. Pregnancy and Neonatal Outcomes: The remaining 89 women delivered live infants between July and August 2023. All newborns underwent standardized postnatal echocardiography. At the 6—month assessment, 80 infants (89.9%) were found to have a patent foramen ovale (PFO). At the 2—year follow—up, echocardiography confirmed the spontaneous closure of the PFO in all 80 children.Long—term Cardiac Outcome: Apart from the isolated situs inversus with dextrocardia, no other significant intracardiac structural or functional abnormalities were detected in any of the 89 children at their last follow—up visit (up to 2 years of age). Discussion This study observes a temporal overlap between an increase in fetal mirror—image dextrocardia cases and maternal SARS—CoV—2 infection. In most cases, the infection occurred at 4–6 weeks of gestation, which implies a potential link between maternal exposure during this period and fetal cardiac malformation. In the normal human body, two—thirds of the heart is located on the left side of the chest, with the apex pointing toward the left anterior side. Dextrocardia is a rare cardiac positional anomaly in which a large part of the heart is located on the right half of the chest, and its base—to—apex long axis points to the right side. It can be classified into mirror—image dextrocardia, levocardia, and mixed dextrocardia [15].Mirror—image dextrocardia refers to a rare congenital heart defect in which the apex of the heart points towards the right side of the chest, and the position and connections of the ventricles, atria, and large blood vessels are reversed from their normal positions, resembling a mirror image. The major organs in the thorax and abdomen, including the lungs, liver, spleen, and stomach, also exhibit mirror—image symmetry. Although the exact cause of this condition is not yet fully understood, it is thought to occur when early embryonic development of the internal organs favors the right side due to various reasons. During embryonic development, a cavity called the pericardial sac appears in the foregut at 18–19 days of gestation. Mesenchymal cells on the ventral side of the pericardial sac aggregate to form a pair of cell cords called the cardiac cords.As the head folds develop and the pericardial sac and cardiac cords turn toward the ventral side of the pharynx, the cardiac cords develop clefts and form two parallel longitudinal tubes called the heart tubes. Approximately on day 22, the heart tubes fuse to form the primitive heart tube, which consists of the truncus arteriosus, bulbus cordis, primitive ventricle, primitive atrium, and sinus venosus. The primitive heart tube bends and folds to form the basic structure of the right ventricle [16].The regulatory mechanism of heart laterality is exceptionally intricate, with more than 20 genes known to be involved. The most extensively studied genes associated with this mechanism include LEFTY1, LEFTY2, PITX2, LRD, and KIF3B [17–19]. These genes play roles at different stages and sites, causing the normal heart and visceral organs to deviate towards the left, whereas the cardiac apex points towards the left, creating a normal left—positioned cardiac structure.However, when this process is disrupted by certain factors, the primitive heart tube bends toward the left during heart formation, causing the cardiac axis to point downward and toward the right, with the cardiac apex located within the right thoracic cavity. Simultaneously, the rotation of the viscera changes from right to left, resulting in a complete inversion of the visceral atria, forming a mirrored structure known as the mirror—image dextrocardia. In addition to genetic factors, the formation mechanism of dextrocardia involves ciliary movement during the embryonic period, which generates a fluid flow that disrupts the left–right symmetry of the primitive heart tube. This process activates the Nodal-Pitx2 signaling pathway, which regulates the development of visceral asymmetry, causing it to rotate from right to left and ultimately forming mirror-image dextrocardia [20, 21]. Primary ciliary dyskinesia (PCD) is a rare genetic disease that can be inherited in an autosomal recessive or X-linked manner, with a prevalence ranging from 1/20,000 to 1/10,000 [22, 23]. There are various types of PCD, including immotile cilia syndrome, Kartagener syndrome (KS), ciliary dyskinesia, and primary ciliary orientation disorders. Currently, the incidence of situs inversus in KS in China is as high as 95.4% [24], whereas reports in Europe indicate that only 40%–55% of patients with PCD have situs inversus [25]. More than 50 genes associated with PCD have been reported, with common pathogenic variations primarily involving DNAH5, DNAI1, DNAAF1, CCDC39, and CCDC40 genes [26, 27]. In this study, two pregnant women were found to carry DNAH5 and DNAH11 gene mutations through whole-exome genetic testing, which is consistent with previously reported findings. PCD is generally associated with several ultrastructural defects, including outer dynein arm defects, inner and outer dynein arm deficiencies, and microtubular disorganization.accompanied by inner dynein arm deficiencies. Approximately 30% of patients with genetically confirmed PCD have normal or near-normal ultrastructure [28]. This is related to mutations in genes that encode structural proteins that do not affect the integrity of dynein arms. Therefore, although genes related to PCD are detected through genetic testing of fetal samples, this does not necessarily mean that the fetus will be diagnosed with PCD after birth. The corresponding clinical manifestations may occur only when these genes are expressed in proteins associated with PCD. Thus, if fetuses are diagnosed with situs inversus and genes associated with PCD are detected during the fetal period, close observation can be conducted after birth to determine whether the clinical manifestations of PCD appear. Mirror—image dextrocardia is rare, with varying incidences among studies and countries. According to the literature, the incidence ranges from 1/8,000 to 1/20,000 [29], and no significant differences are observed in terms of ethnicity or gender [30]. In adults, the incidence of mirror—image dextrocardia is 1/12,000 [31, 32], while in fetuses, the incidence rate is 0.8/10,000 [33]. Rajesh et al. estimated the prevalence of mirror—image dextrocardia in all age groups to be 1.2/10,000, with a slightly higher incidence rate in neonates (2.9/10,000) [34]. To date, no reports are available on the incidence of mirror—image dextrocardia in fetuses in China. Following the Chinese government's lifting of COVID—19 restrictions on December 7, 2022, approximately 82.4% of the Chinese population was infected by February 7, 2023 [9]. Consequently, pregnant women were inevitably infected as well. We conducted an epidemiological survey on the incidence of mirror—image dextrocardia in three hospitals in Shaanxi Province prior to the COVID—19 pandemic and during the controlled and uncontrolled periods. The survey revealed incidence rates of 2.2/10,000, 0.9/10,000, and 18.2/10,000 respectively, which were consistent with those reported in previous studies. The difference in incidence rates between 2019 and 2022 was statistically insignificant; however, the lifting of COVID—19 restrictions led to an exponential increase in the incidence rate (18.2/10,000), which is approximately 8–20 times higher than those in 2019 and 2022. This high incidence rate has not been previously reported.Therefore, on the one hand, we maintain that from the initial outbreak of COVID—19 in China in December 2019 to the full implementation of epidemic prevention and control measures until December 2022, the Chinese government has made tremendous efforts in terms of manpower, materials, and financial resources to curb the pandemic. These measures have played an outstanding protective role in safeguarding maternal health and normal fetal development.On the other hand, potential ascertainment bias and inconsistencies in diagnostic criteria may exist. For example, enhanced surveillance intensity, the widespread increase in ultrasound examinations after lockdowns were lifted, or reporting bias in online research cohorts could all contribute to the observed findings. After discovering an explosive increase in the incidence of mirror—image dextrocardia following the COVID—19 pandemic in Shaanxi Province, we conducted an online epidemiological investigation of 111 pregnant women with fetal mirror—image dextrocardia in various regions of China.We found that most pregnant women had their last menstrual period between November 1 and November 20, 2022, and most of them were infected with the SARS—CoV—2 around mid—December 2022. Additionally, there was a difference of approximately 4–6 weeks between the last menstrual period and the time of SARS—CoV—2 infection.Furthermore, when we shifted the daily number of SARS—CoV—2 infection curve by 5 weeks, it coincided exactly with the peak of the number of pregnant women’s last menstrual periods per day.Therefore, we concluded that all 111 pregnant women with fetal mirror—image dextrocardia were infected with COVID—19 approximately 5 weeks after conception. This crucial period of 5 weeks after conception coincides with the development of the heart embryo at approximately 3 weeks.Hence, we believe that the abrupt rise in the incidence of mirror—image dextrocardia following the COVID—19 outbreak was temporally associated with the widespread SARS—CoV—2 infection event in mid—December 2022. The clinical manifestations of COVID-19 are diverse. Our results showed that pregnant women with fetal mirror-image dextrocardia and SARS-CoV-2 infection mainly exhibited symptoms such as fever, cough, phlegm, sore throat, drowsiness, and body aches. In humans, SARS-CoV-2 primarily affects the upper respiratory tract and lungs, leading to pulmonary fibrosis and respiratory failure in severe cases. Additionally, the novel coronavirus can invade other organs, such as the liver, kidneys, nervous system, and immune system, causing liver and kidney dysfunction, myocardial injury, and central nervous system damage. Importantly, there have been reports of severe COVID-19 leading to stillbirths and premature births [35], highlighting the impact of COVID-19 on pregnancy. However, mother-to-child transmission of SARS-CoV-2 remains controversial [36].Our results suggest that COVID—19 may be associated with the formation of mirror—image dextrocardia during early pregnancy, leading to abnormal embryonic development in pregnant women. Mirror—image dextrocardia is characterized by abnormal heart positioning, while most cardiac structures remain normal.Numerous reports have indicated that mirror—image dextrocardia is associated with cardiovascular malformations. It has been reported that 96% of patients with mirror—image dextrocardia have isolated dextrocardia, whereas the remaining 4% have associated congenital abnormalities, such as atrial septal defects, ventricular septal defects, patent ductus arteriosus, Tetralogy of Fallot, and other heart diseases [37].This study examined 111 pregnant women with fetal mirror—image dextrocardia and found that 95 fetuses (85.6%) had isolated dextrocardia, representing a decrease of nearly 10% from that of previous reports. Conversely, the proportion of fetuses with mirror—image dextrocardia combined with congenital heart defects was significantly higher than that reported in previous studies (14.4% vs 4%).The cardiac abnormalities associated with dextrocardia in these fetuses included interrupted inferior vena cava, ventricular septal defects, atrial septal defects, left atrial isomerism, right—sided aortic arch, aberrant left subclavian artery, single ventricle, and persistent truncus arteriosus. In pregnant women with fetal mirror-image dextrocardia, the first step was to determine the presence of associated cardiovascular anomalies. In the event that no such anomalies are detected, cardiac hemodynamics and function can be normal with no special treatment required. For pregnant women whose fetuses had isolated mirror-image dextrocardia, we provide positive psychological counseling to explain the pathological and physiological changes in the fetus, relieving their anxiety and panic and enabling them to continue pregnancy with peace of mind. For those with concomitant intracardiac abnormalities, different treatment options should be provided depending on the individual’s cardiac pathology. Surgical correction of malformations after birth is the preferred method for patients with mirror image dextrocardia and concurrent Tetralogy of Fallot. For patients with mirror-image dextrocardia and concurrent ventricular septal defects, appropriate treatment methods should be selected based on the size and type of defect. In summary, postnatal treatment methods should be determined according to the specific structural abnormalities of the heart. Whether further chromosomal or even whole-exome genetic testing needs to be performed for pregnant women with fetal mirror-image dextrocardia to exclude diseases such as PCD or KS should be determined based on multiple factors, including the local medical environment, economic conditions of pregnant women, and family expectations for the fetus. Approximately 70% of pregnant women in this group underwent or planned to undergo further genetic testing. Two cases of DNAH5 and DNAH11 were identified using whole-exome sequencing; however, their pathogenicity was unclear. This study highlighted a significant increase in the occurrence of fetal mirror-image dextrocardia among pregnant women at approximately 5 weeks of gestation in the period before and after the lifting of COVID-19 restrictions in China. However, due to limitations in our epidemiological survey sample size and limited coverage to three hospitals in Xi'an, Shaanxi Province, we aim to expand our study in collaboration with multiple centers nationwide to achieve a larger sample size. Furthermore, we plan to obtain data on the number of pregnant women undergoing prenatal ultrasound examinations concurrently with an expanding national sample size of positive cases, which will allow us to calculate the incidence of mirror-image dextrocardia in China. This epidemiological survey ended in late April 2023, and the expected delivery date for the pregnant women was August 2023. As our data thus far have come solely from fetal echocardiography, we aim to conduct further follow-up studies after the birth of the fetuses with mirror-image dextrocardia in August 2023 to evaluate the impact of COVID-19 on them. Finally, this study primarily focused on conducting an epidemiological investigation of pregnant women with fetal mirror-image dextrocardia, and the results suggested a close association between the increased incidence and SARS-CoV-2 infection. However, as we have not delved into the pathogenic mechanism behind this finding, we hope that further studies will elucidate this phenomenon. It should be noted that this study has several inherent limitations that need to be acknowledged. First, data from the second—phase investigation were collected through a retrospective online questionnaire, which inevitably introduces potential recall bias and selection bias. Information on SARS—CoV—2 infection timing and clinical manifestations was self—reported by participants. Although we defined the infection date based on nucleic acid testing results from the nationwide routine daily screening during the December 2022 COVID—19 surge to improve accuracy, memory—related errors and subjective reporting bias could not be completely excluded.Second, participants were recruited via online national platforms, which may lead to non—random sampling and limit the generalizability of our findings.In view of these methodological constraints, we have avoided over—interpreting the results and drawn conclusions prudently in this study. Therefore, our study design only demonstrates an association between the post—control recovery phase and the observed epidemiological phenomenon of fetal mirror—image dextrocardia. Conclusions Through epidemiological surveys conducted in multiple provinces before and after the lifting of COVID—19 control measures in China, we found a significant increase in the incidence of mirror—image dextrocardia in the fetuses of pregnant women infected with SARS—CoV—2. In particular, approximately 85.6% of dextrocardia cases occurred when pregnant women were infected with SARS—CoV—2 during weeks 4–6 of pregnancy, highlighting the close relationship between SARS—CoV—2 infection and dextrocardia formation during early pregnancy.It should be noted that our study design only demonstrates an association between the post—control recovery phase and the observed epidemiological phenomenon of fetal mirror—image dextrocardia. Nevertheless, whether a causal relationship exists between them remains unclear, which requires further large—sample clinical studies and fundamental experimental verification. Acknowledgements We would like to thank Editage (www.editage.cn) for English language editing. Authors’ contributions Wenjiao Xu, Yajuan Wei,Enfa Zhao, and Baomin Liu conceived the study. Xinru Gao, Xiaoxue Yang, Jianrong Gao, Shanying He, Huanhuan Huo, Min Qiao, Xiaohua Dong collected the data. Wenjiao Xu, Yajuan Wei and Enfa Zhao prepared Fig. 1–5. Wenjiao Xu, Yajuan Wei and Enfa Zhao wrote the main manuscript text. All authors reviewed the manuscript. Funding None. Data availability The datasets generated during and/or analyzed during the current study are available from the correspondingauthor(XWJ3078117948163.com,Enfa Zhaozhaoenfasy@163.com or Dr.liubm@xjtu.edu.cn) upon reasonable request. Declarations Ethics approval and consent to participate The study was conducted in accordance with the guidelines of the Declaration of Helsinki. All participants provided written informed consent prior to enrollment. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Wenjiao Xu, Email: XWJ3078117948@163.com. Enfa Zhao, Email: zhaoenfasy@163.com. Baomin Liu, Email: Dr.liubm@xjtu.edu.cn. References Associated Data Data Availability Statement The datasets generated during and/or analyzed during the current study are available from the correspondingauthor(XWJ3078117948163.com,Enfa Zhaozhaoenfasy@163.com or Dr.liubm@xjtu.edu.cn) upon reasonable request.